Losartan and Social Processing

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions

Social Cognition

Interventions

DRUG

Losartan potassium 50mg

Single dose losartan (50 mg), encapsulated identically to placebo.

OTHER

Placebo

Single tablet encapsulated identically to placebo.

Trial Locations (1)

RECRUITING

Warneford Hospital, Oxford

All Listed Sponsors

collaborator

Oxford Health Biomedical Research Centre (OH BRC) support scheme

UNKNOWN

lead

University of Oxford

OTHER

NCT06624904 - Losartan and Social Processing | Biotech Hunter | Biotech Hunter